GHA Q&A with Rapidly-Expanding ENT & Allergy Platform SENTA Partners

Southern Ear, Nose, Throat & Allergy Partners (SENTA Partners) is a community of ENT and allergy specialists founded in 2019 and located in the Southeast. Backed by Shore Capital Partners, a healthcare-focused lower-middle-market private equity (PE) firm, SENTA focuses on both the ENT and allergy specialties. Here, SENTA VP of M&A and Corporate Development John Bennett and CEO Adam Low talk to Global Healthcare Advisors (GHA) about SENTA’s outlook on the market and expansion plans.

SENTA Partners Completes 3rd Affiliation in Two Months through Partnership with Valdosta ENT

Southern Ear Nose Throat & Allergy (“SENTA”) Partners is pleased to announce that it has completed an affiliation with ENT & Allergy Associates of South Georgia and ENT of South Georgia Surgery Center (collectively, “Valdosta ENT”). SENTA is an ENT and allergy management services organization backed by Shore Capital Partners, and is committed to partnering with leading physicians to build a premier network of ENT and allergy practices in the South. Valdosta ENT is the premier provider of specialty otolaryngology services across South Georgia and also offers patients tailored surgical solutions at its ambulatory surgery center. Valdosta ENT employs approximately 26 clinical and administrative staff between the clinical location and the surgery center, both located in Valdosta, Georgia.

10 Facts and Statistics on Otolaryngology | 2020

Here are 10 things to know about otolaryngology and otolaryngologists, according to Becker’s ASC Review.

SENTA Expands Presence to 50 Providers and 23 Clinical Locations in Metro Atlanta through Affiliation with Atlanta Allergy & Asthma

Southern Ear Nose Throat & Allergy (“SENTA”) Partners is pleased to announce that it has completed an affiliation with Atlanta Allergy & Asthma (“Atlanta Allergy”). SENTA is an ENT and allergy management services organization backed by Shore Capital Partners committed to partnering with leading physicians to build a premier network of ENT and allergy practices in the South. For almost 50 years, Atlanta Allergy has been the leading provider of quality care, research and clinical innovation in the field of allergy, asthma and immunology throughout the greater Atlanta metropolitan area and other parts of Georgia. With 15 board-certified physicians and 10 advanced practice providers, Atlanta Allergy provides services from its 17 office locations. Additionally, Atlanta Allergy is the only National Allergy Bureau certified pollen counting station in the Atlanta area.

Anthem to Study Whether Apple Watch Could Help People with Asthma

Anthem, the second largest insurer in the U.S., is teaming up with Apple and a range of other collaborators on a study to investigate how people diagnosed with asthma could use consumer devices, like Apple Watch, to better manage their condition. The two-year study is looking at whether data collected from the iPhone and Apple Watch can help people with asthma predict potentially serious outcomes, which could lead to hospitalization. About 1.8 million people end up in emergency rooms from asthma each year. 1 in 14 people overall have the condition. That makes asthma a big source of cost for health plans, including Anthem, which offers coverage to both commercial populations and lower-income populations through Medicaid. Anthem has said that it intends to recruit a diverse study population.

Federal Committee Approves Asthma-Related Value-Based Pay Model

The federally appointed Physician-Focused Payment Model Technical Advisory Committee said Tuesday it has recommended HHS consider a payment model focused on asthma care. The payment model, if approved by HHS, would provide allergists, immunologists and pulmonologists a value-based payment option. A longstanding complaint of the movement to alternative payment models is it has excluded many specialists from participating because quality metrics don’t apply to their practice. The model can also be used by primary care doctors who also treat patients with asthma.

SENTA Partners Doubles Physician Presence in Atlanta Through Affiliation with Piedmont ENT

Southern Ear Nose Throat & Allergy (“SENTA”) Partners is pleased to announce that it has completed an affiliation with Piedmont Ear, Nose, Throat & Related Allergy (“Piedmont”). Piedmont ENT employs approximately 50 clinical and administrative staff at the practice location in the Buckhead community of Atlanta, Georgia. SENTA is an ENT and allergy management services organization backed by Shore Capital Partners, and is committed to partnering with leading physicians to build a premier network of ENT and allergy practices in the South.

Lovelace Medical Group Closes Acquisition of Head & Neck Surgeons of New Mexico

Lovelace Medical Group on Tuesday closed a deal to acquire Head and Neck Surgeons of New Mexico. The specialty care firm, which treats the ear, nose and throat, is now part of Lovelace’s statewide care network. Dr. Jason Mudd, a physician at the former Head and Neck Surgeons of New Mexico (HNSNM), confirmed the transaction. As part of the acquisition, Head and Neck Surgeons of New Mexico is now called Lovelace Medical Group Ear Nose and Throat. A total of 21 HNSNM employees are now part of Lovelace Health System’s workforce of more than 4,200 in New Mexico.

Family Allergy & Asthma Expands with Acquisition in Arkansas

Louisville-based Family Allergy & Asthma is acquiring Arkansas Allergy and Asthma Clinic, a little Rock-based allergy specialty practice. In a news release, Family Allergy & Asthma referred to it as a “strategic affiliation” but clarified that it was an acquisition in which management was being combined and individual brand names were being retained. The deal closed on Monday but financial terms were not disclosed in the release.

Lovelace Medical Group Signs Agreement to Acquire Head & Neck Surgeons of New Mexico

Lovelace Medical Group announced today it has signed an agreement to acquire Head & Neck Surgeons of New Mexico (HNSNM), one of the state’s top Ear, Nose & Throat (ENT) physician specialty groups. This transaction solidifies a long-standing relationship between Lovelace and HNSNM, further enhancing the continuum of specialty care services Lovelace offers to the communities it serves. The closing date will be September 1.